Eledon Pharmaceuticals, Inc. - ELDN

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G/A BIOTECHNOLOGY VALUE FUND L P 6.8% 5,382,084 View
May 15, 2026 SCHEDULE 13G/A BVF I GP LLC 6.8% 5,382,084 View
May 15, 2026 SCHEDULE 13G/A BIOTECHNOLOGY VALUE FUND II LP 2.7% 2,057,090 View
May 15, 2026 SCHEDULE 13G/A BVF II GP LLC 2.7% 2,057,090 View
May 15, 2026 SCHEDULE 13G/A Biotechnology Value Trading Fund OS LP 0.4% 301,588 View
May 15, 2026 SCHEDULE 13G/A BVF Partners OS Ltd. 0.4% 301,588 View
May 15, 2026 SCHEDULE 13G/A BVF GP HOLDINGS LLC 9.4% 7,439,174 View
May 15, 2026 SCHEDULE 13G/A BVF PARTNERS L P/IL 9.99% 7,868,419 View
May 15, 2026 SCHEDULE 13G/A BVF INC/IL 9.99% 7,868,419 View
May 15, 2026 SCHEDULE 13G/A LAMPERT MARK N 9.99% 7,868,419 View
Mar 26, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Feb 17, 2026 SCHEDULE 13G/A RA Capital Management, L.P. 0.0% 0 View
Feb 17, 2026 SCHEDULE 13G/A Peter Kolchinsky 0.0% 0 View
Feb 17, 2026 SCHEDULE 13G/A Rajeev Shah 0.0% 0 View
Feb 17, 2026 SCHEDULE 13G/A RA Capital Healthcare Fund, L.P. 0.0% 0 View
Feb 13, 2026 SCHEDULE 13G/A Coastlands Capital LP 4.99% 3,937,826 View
Feb 13, 2026 SCHEDULE 13G/A Coastlands Capital Partners LP 4.99% 3,937,826 View
Feb 13, 2026 SCHEDULE 13G/A Coastlands Capital GP LLC 4.99% 3,937,826 View
Feb 13, 2026 SCHEDULE 13G/A Coastlands Capital LLC 4.99% 3,937,826 View
Feb 13, 2026 SCHEDULE 13G/A Matthew D. Perry 4.99% 3,908,467 View
Jan 21, 2026 SCHEDULE 13G/A BlackRock, Inc. 4.6% 3,625,824 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.